Researchers from the Monash Milk Team have published a new study demonstrating the power of human milk as a highly effective ...

HOUSE, Pa. - Johnson & Johnson (NYSE: NYSE:JNJ) has released new data on nipocalimab, an investigational drug with potential to treat diseases driven by immunoglobulin G (IgG) antibodies. Published in ...

US-based biotechnology company Rallybio has dosed the first subject in a Phase II trial evaluating RLYB212 as a potential ...

Arkstone, the leader in laboratory infectious disease guidance and antimicrobial stewardship, proudly introduces NeoSuretm, a significant expansion of its OneChoice platform. Building upon OneChoice's ...

Though some outcomes were also poorer with an interval less than a year, these were less clinically significant, experts say.

Tempus AI, Inc. , a technology company leading the adoption of AI to advance precision medicine and patient care, today announced a new collaboration with the Institute for Follicular Lymphoma ...

A young patient identified by the ELSA study as having early stages of Type 1 Diabetes, has received treatment to delay the ...

Indoor lambing has benefits, but infections are a major risk. Learn how to reduce neonatal losses, improve hygiene, and protect your flock.

For infants born before 34 weeks of gestation and with a birth weight <1,000 g, probiotics used in neonatal units are ...

Children with rheumatic diseases may face increased risks for COVID-19-related hospitalization, particularly those using glucocorticoids, rituximab, or mycophenolate.

Babies born during the COVID-19 pandemic had much lower risk for respiratory infections and antibiotic prescriptions during their first 18 months.